4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-15-015613
CIK 0001328143operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:11 PM ET
Size
8.3 KB
Accession
0001209191-15-015613
Insider Transaction Report
Form 4
BOOTH RICHARD H
Director
Transactions
- Sale
Common Stock
2015-02-17$16.54/sh−1,000$16,540→ 49,778 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:11 PM ET
- Size
- 8.3 KB